kinetics during moderate-and heavy-intensity exercise after acetazolamide administration. J. Appl. Physiol. 86(5): 1534-1543, 1999.-The effect of carbonic anhydrase inhibition with acetazolamide (Acz) on CO 2 output (V CO 2 ) and ventilation (V E) kinetics was examined during moderate-and heavy-intensity exercise. Seven men [24 Ϯ 1 (SE) yr] performed cycling exercise during control (Con) and Acz (10 mg/kg body wt iv) sessions. Each subject performed step transitions (6 min) in work rate from 0 to 100 W [below ventilatory threshold (ϽV ET)] and to an O 2 uptake corresponding to ϳ50% of the difference between the work rate at V ET and peak O 2 uptake [above ventilatory threshold (ϾV ET)]. V E and gas exchange were measured breath by breath. The time constant () was determined for exercise ϽV ET by using a single-exponential model (fit between 20 s and end-exercise); the mean response time (MRT) was determined for exercise Ͼ V ET by using a three-component model (fit from the start of exercise). V CO 2 kinetics were slower in Acz (ϽV ET, ϭ 45 Ϯ 6 s; ϾV ET, MRT ϭ 75 Ϯ 10 s) than Con (ϽV ET, ϭ 34 Ϯ 6 s; ϾV ET, MRT ϭ 54 Ϯ 7 s). During ϽV ET exercise, V E kinetics were slower in Acz ( ϭ 48 Ϯ 6 s) than Con ( ϭ 34 Ϯ 6 s), but ϾV ET kinetics were faster in Acz (MRT ϭ 85 Ϯ 17 s) than Con (MRT ϭ 106 Ϯ 16 s). Carbonic anhydrase inhibition slowed V CO 2 kinetics during both moderate-and heavy-intensity exercise, demonstrating impaired CO 2 elimination in the nonsteady state of exercise. The slowed V E kinetics in Acz during exercise ϽV ET is consistent with a mechanism coupling V E kinetics with the flow of CO 2 to the lungs. control of breathing; carbonic anhydrase; end-tidal partial pressure of carbon dioxide; carbon dioxide output kinetics; ventilation kinetics CARBONIC ANHYDRASE (CA), the enzyme that catalyzes the reversible hydration-dehydration reaction involving CO 2 -HCO 3 Ϫ , plays an important role in facilitating the transport of CO 2 from the active tissues to the lungs, where it is eliminated. In general, evidence suggests that, during whole body exercise in humans, CA inhibition does not impair CO 2 output (V CO 2 ) at rest or during the steady state of moderate-intensity exercise (24) but may reduce V CO 2 during maximal exercise (14, 15, 22) . Whereas most studies focus on the transport and elimination of CO 2 during steady-state conditions, no information is available on the effects of CA inhibition on the kinetics of V CO 2 in the nonsteady state of whole body exercise in humans. We hypothesized that slowed V CO 2 kinetics may contribute, in part, to the lower peak V CO 2 observed during CA inhibition in maximal exercise (14, 15, 22) . A slowing of V CO 2 kinetics may occur with CA inhibition, as there appears to be CO 2 retention in the tissues with increasing exercise intensities (24). This increase in CO 2 storage may cause V CO 2 kinetics to be slowed in a manner similar to the slowed response observed when the capacitance for CO 2 storage is increased by prior hyperventilation (31). Additionally, if the exercise intensity is moderate, the kinetics of ventilation (V E) may also be slowed under conditions of CA inhibition, given the demonstrated coupling between V CO 2 and V E (31). At higher exercise intensities associated with a sustained increase in plasma lactate concentration ([La Ϫ ] pl ), V CO 2 and V E kinetics become more complex as the contribution of CO 2 from nonmetabolic sources to V CO 2 increases (i.e., buffering of lactic acid by bicarbonate and a reduction in CO 2 stores by hyperventilation), and V E is stimulated by the developing metabolic acidosis. Typically, V CO 2 kinetics are unchanged, whereas V E kinetics are slowed as exercise intensities increase (8). This increase in CO 2 production may provide an additional CO 2 load that may, under conditions of CA inhibition, result in a further slowing of V CO 2 kinetics.
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There is evidence from both animal (12, 13, 26, 27 ) and human (23, 28) studies demonstrating an attenuated or abolished peripheral chemoreceptor response after acetrazolamide (Acz) administration. In humans, the kinetics of the V E response appear to be influenced by the peripheral chemoreceptor drive, particularly during the nonsteady state of exercise (for review see Ref. 29) . The effect of Acz administration on the peripheral chemoreceptor and the ensuing V E response during the onset of either moderate-or heavy-intensity exercise is not known. A slowed ventilatory response may be observed, independent of V CO 2 kinetics, if the peripheral chemoreceptor is functionally inhibited by Acz.
Thus the purpose of this study was to examine the effect of acute Acz-induced CA inhibition on the kinetics of V CO 2 and V E during the on-transition to moderateintensity [i.e., below the ventilatory threshold (ϽV ET)] and heavy-intensity [i.e., above the ventilatory threshold (ϾV ET)] constant-load exercise. A slowing of V CO 2 kinetics during the on-transient of exercise would be consistent with CA being functionally significant in the facilitation of CO 2 transport and elimination during whole body exercise, particularly in the nonsteady state of exercise. In addition, a slowing of V E kinetics during CA inhibition would be an expected consequence
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. of slowed V CO 2 kinetics, if a tight coupling between V CO 2 and V E is causally related. Alternatively, slowed V E kinetics may be expected independent of V CO 2 kinetics, if CA inhibition affects peripheral chemoreceptor function.
METHODS
Subjects. Seven healthy male subjects [age 24 Ϯ 1 (SE) yr, height 178 Ϯ 1 cm, and weight 80 Ϯ 3 kg] participated in this study. The experimental protocol and all possible risks associated with participation in the study were outlined, and informed consent was obtained from each subject. The study was approved by The University of Western Ontario Review Board for Health Sciences Research involving Human Subjects.
General protocol, materials, and methods. Each subject performed preliminary testing consisting of an incremental exercise test to volitional fatigue in which the work rate increased as a ramp function by 25 W/min. Exercise was performed on an electromagnetically braked cycle ergometer (model H-300-R, Lode). The ventilatory threshold (V ET) and peak O 2 uptake (V O 2 peak ), defined as the highest O 2 uptake (V O 2 ) averaged over a 20-s interval, were determined from the incremental exercise test. The V ET was defined as the V O 2 at which there was a systematic increase in the ventilatory equivalent for V O 2 (V E/V O 2 ) and end-tidal PO 2 (PET O 2 ) with no concomitant increase in the ventilatory equivalent for V CO 2 (V E/V CO 2 ) or decrease in end-tidal PCO 2 (PET CO 2 ).
The subjects were further studied on six separate occasions: three each for control (Con) and after administration of Acz. The subjects reported to the laboratory after consuming only a light meal and abstaining from exercise and caffeinated beverages for at least 12 h preceding the test. Each subject was tested at the same time of the day during all conditions. On one occasion during Con and before each of the Acz studies, the subjects rested supine while a percutaneous Teflon catheter (Angiocath, 21 gauge) was placed into a dorsal hand vein to facilitate blood sampling and Acz administration. The blood was arterialized by wrapping the hand and forearm in a heating pad. After 15 min of rest after catheterization, a blood sample was drawn (preinfusion), followed by Acz infusion (10 mg/kg iv) over a 3-min period during Acz studies. After an additional 30 min of rest, a blood sample was drawn (postinfusion) and the subject moved to the cycle ergometer where loadless cycling was immediately initiated. Measurements of gas exchange and V E were made throughout the exercise protocol; blood samples were obtained during loadless cycling (0 W) 1 min before the onset of exercise and at 0, 15, 30, and 45 s and at 1, 1.5, 2, 3, 4, and 6 min during the exercise bout (i.e., time 0 ϭ onset of exercise transition).
For the determination of V CO 2 and V E kinetics, each subject performed two step transitions to an absolute work rate ϽV ET (100 W) and one transition to a work rate ϾV ET. The exercise intensity ϾV ET corresponded to a work rate estimated to elicit a V O 2 equivalent to V ET plus ϳ50% of the difference between the V O 2 at V ET and V O 2 peak . The exercise protocol was performed during six visits to the laboratory (3 visits for each condition) for a total of six repetitions for the moderate-and three repetitions for the heavy-intensity exercise; the two moderate-intensity exercise bouts always preceded the heavy-intensity exercise bout. Each step transition in work rate was 6 min in duration with 6 min of loadless cycling (0 W) between each bout. The Con and Acz exercise sessions were performed in a randomized order. We noted, during pilot studies, that minor side effects associated with this high dose of Acz were noticeable by the subjects, and, therefore, no placebo was used in the present study.
Inspired and expired airflow and volumes were measured during exercise by a low-resistance, low-dead-space (90 ml) bidirectional turbine and volume transducer (VMM-110, Alpha Technologies), which was calibrated before each test with a syringe of known volume (990 ml). Respired gases were sampled continuously at the mouth (1 ml/s) by a mass spectrometer (MGA-1100, Perkin Elmer) for determination of the fractional concentrations of O 2 , CO 2 , and N 2 . The mass spectrometer was calibrated with precision-analyzed gas mixtures before each test. Analog signals from the mass spectrometer and turbine transducer were sampled every 20 ms and stored on disk for later analysis. Breath-by-breath computations for V O 2 , V CO 2 , V E, PET O 2 , and PET CO 2 were performed after accounting for delays in the gas-exchange analysis system and fluctuations in lung-gas stores in the computer algorithms (1) . Corrections for temperature and water vapor were made for conditions measured near the mouth. Heart rate was monitored by using an electrocardiogram with the electrodes placed in a modified V-5 configuration.
Arterialized venous blood was drawn into syringes containing lithium heparin, mixed, placed in a slurry of ice and water, and analyzed after a short delay. Whole blood samples (200 µl) were analyzed at 37°C for plasma pH, arterial PCO 2 (Pa CO 2 ), and [La Ϫ ] pl by using selective electrodes (Statprofile 9 Blood Gas and Electrolyte Analyzer, Nova Biomedical Canada). The electrodes were calibrated before each test and at regular intervals during analysis. Plasma H ϩ concentration ([H ϩ ]) was calculated from the measured pH; plasma HCO 3 Ϫ concentration ([HCO 3 Ϫ ]) was calculated from the measured pH and Pa CO 2 .
Data analysis. The breath-by-breath data obtained during each of the step increases in work rate were linearly interpolated at 1-s intervals, time aligned, and ensemble averaged to provide a single response for each subject in each condition. The computer model utilized to describe the kinetic response provides an estimate of the baseline (BL), amplitude (Amp), time delay (TD), and time constants (). For step changes in work rate ϽV ET, the kinetic parameters for the on-transition in work rate were determined as a function of time (t) by using a single-exponential model
where Y(t) is either V CO 2 or V E at time t, u ϭ 0 for t ϽTD, and u ϭ 1 for t ϾTD. A single-component model, starting 20 s after the onset of exercise (i.e., phase 1 was ignored), was used to isolate the phase 2 response. In addition, a large overshoot in V E was observed in phase 1 for two subjects, and, therefore, the response could not be adequately described by using a two-component model. For step changes in work rate ϾV ET, the kinetic parameters for the on-transition in work rate were determined by using a three-component exponential model starting at the onset of exercise
where u 1 ϭ 0 for t ϽTD 1 , u 1 ϭ 1 for t ϾTD 1 , u 2 ϭ 0 for t ϽTD 2 , u 2 ϭ 1 for t ϾTD 2 , u 3 ϭ 0 for t ϽTD 3 , and u 3 ϭ 1 for t ϾTD 3 . Model parameters were determined by least squares nonlinear regression in which the best fit was defined by minimiza- tion of the residual sum of squares. The overall time course of the response for exercise ϽV ET and ϾV ET was determined by the MRT. The MRT is equivalent to the time taken to reach ϳ63% of the difference between BL and the new steady-state value.
Statistics. Kinetic parameter estimates were analyzed by using a two-way repeated-measures analysis of variance for Con vs. Acz and moderate-vs. heavy-intensity exercise as the main effects. Blood data were analyzed for condition (Con vs. Acz) and time effects by using a two-way repeated-measures analysis of variance. When condition was not a factor, data were analyzed by using a one-way repeated-measures analysis of variance. A significant F ratio was further analyzed by using Student-Newman-Keuls post hoc analysis. Statistical significance was accepted at P Ͻ 0.05. All values are reported as means Ϯ SE.
RESULTS
The V O 2 peak achieved by the subjects during the preliminary ramp exercise test was 53.8 Ϯ 2.3 ml · kg Ϫ1 · min Ϫ1 . The work rates utilized during the constant-load tests were 100 W (74 Ϯ 3% V ET) and 237 Ϯ 9 W (138 Ϯ 2% V ET; 51 Ϯ 1% of ϳ50% of the difference between the V O 2 at V ET and V O 2 peak ) for the ϽV ET and ϾV ET exercise intensities, respectively. The effect of Acz administration on V O 2 kinetics during moderate-and heavy-intensity exercise is reported in detail in a separate communication (21) . Briefly, Acz did not affect either the steady state or the kinetics of the V O 2 response to the step transitions in exercise intensity performed in this study.
V E and gas exchange at rest and during loadless cycling. The ventilatory and gas exchange response to acute Acz administration during loadless cycling is presented in Table 1 . Although no effects of Acz administration were observed for V CO 2 or V E during loadless cycling, the V E/V CO 2 was higher (P Ͻ 0.05) in Acz than in Con. PET O 2 was similar between conditions, but, during loadless cycling, PET CO 2 was lower (P Ͻ 0.05) during Acz.
Acid-base status during moderate-and heavy-intensity exercise. The effect of acute Acz administration on the acid-base status in equilibrated plasma is presented in Table 1 and Fig. 1 . Acz was administered acutely to examine the effect of CA inhibition on V CO 2 and V E kinetics without the confounding influence of a metabolic acidosis that occurs when Acz is administered chronically. The ϽV ET and ϾV ET protocols were completed in a single testing session, and thus the preand postinfusion values for resting blood data were determined before the ϽV ET exercise bout (Table 1) (Fig. 1, A and B (Fig. 1,  C and D) . Plasma Pa CO 2 was similar at rest and during loadless cycling in Con and Acz (Table 1) . Plasma Pa CO 2 remained at rest levels throughout moderate-intensity exercise in both conditions (Fig. 1E) . During heavyintensity exercise, Pa CO 2 decreased (P Ͻ 0.05) in Con but remained at rest levels in Acz (Fig. 1F) ; Pa CO 2 was higher (P Ͻ 0.05) in Acz than Con at the end of heavy-intensity exercise.
V CO 2 and V E kinetics during moderate-intensity exercise. A summary of the model parameters derived for V CO 2 and V E during the on-transient to a step increase in work rate of moderate intensity is presented in Table  2 . The response of a single subject and the group mean response to a step increase to moderate-intensity exercise are presented in Figs. 2 and 3 , left, respectively. The increase in V CO 2 from loadless cycling to endexercise was similar between conditions, resulting in a similar end-exercise V CO 2 (Con, 1.687 Ϯ 0.055 l/min; Acz, 1.625 Ϯ 0.048 l/min). Compared with Con, the increase in V E from loadless cycling was greater (P Ͻ 0.05) in Acz, so that the end-exercise V E was also higher Phase 2 kinetics for V CO 2 and V E during moderateintensity exercise are presented in Table 2 . Both the BL and Amp for V CO 2 were similar between Con and Acz. V CO 2 was slowed (P Ͻ 0.05) during Acz (45 Ϯ 6 s) compared with Con (34 Ϯ 6 s). BL V E was similar in Con and Acz studies; the Amp for V E was higher (P Ͻ 0.05) in Acz (19.4 Ϯ 1.0 l/min) than Con (14.2 Ϯ 1.3 l/min). Compared with Con, the V E was slowed (P Ͻ 0.05) in Acz (Acz, 48 Ϯ 8 s; Con, 34 Ϯ 6 s).
V CO 2 and V E kinetics during heavy-intensity exercise. The model parameters determined for V CO 2 and V E during the on-response for a step increase to heavyintensity exercise are summarized in Table 3 . The response of a single subject and the group mean response to heavy-intensity exercise are presented in Figs. 4 and 3 , right, respectively. Although the total Amp (Con, 3,019 Ϯ 124 ml/min; Acz, 2,979 Ϯ 146 ml/min) and end-exercise V CO 2 (Con, 3.816 Ϯ 0.218 l/min; Acz, 3.657 Ϯ 0.134 l/min) were similar in Con and Acz, Amp 2 was lower (P Ͻ 0.05) and Amp 3 was higher during Acz than Con. The overall time course for the increase in V CO 2 , as determined by the MRT, was slower (P Ͻ 0.05) in Acz (75 Ϯ 10 s) than in Con (54 Ϯ 7 s), although the kinetic parameters, TD and , for the individual components of the exponential model were similar in Con and Acz.
Although BL V E was similar between conditions, the end-exercise V E was higher (P Ͻ 0.05) during Acz (124.2 Ϯ 6.6 l/min) than Con (111.7 Ϯ 8.6 l/min). V E on-kinetics, as determined by the MRT, were faster (P Ͻ 0.05) in Acz (85 Ϯ 17 s) than Con (106 Ϯ 16 s). The faster MRT was associated with a faster (P Ͻ 0.05) 3 during Acz than Con, as there were no other differences in the model parameter estimates.
DISCUSSION
This is the first study to examine the effects of Acz-induced CA inhibition on the kinetic responses of V CO 2 and V E during whole body exercise in humans. The unique findings of this study were that, compared with the uninhibited condition, V CO 2 kinetics were slowed during the on-transient to both moderate-and heavy-intensity exercise after CA inhibition with no effect on the steady-state V CO 2 response. Whereas V E kinetics were also slowed during the on-transient of moderate-intensity exercise in Acz, they became faster during heavy-intensity exercise with CA inhibition.
Limitations due to CA inhibition. A limitation of the present study and other studies examining the effect of CA inhibition on CO 2 transport and ventilatory control is the CO 2 -HCO 3 Ϫ disequilibrium that exists in tissue and pulmonary capillary blood (3, 4, 7, 24) . Acz administration resulted in a negative end-tidal-arterial PCO 2 difference during moderate-and heavy-intensity exercise (Fig. 5 ) consequent to the Pa CO 2 (measured at equilibrium) being consistently higher than PET CO 2 . This finding, consistent with previous studies (14, 25) , reflects the slower rate of CO 2 formation from plasma and erythrocyte HCO 3 Ϫ during the relatively short pulmonary capillary transit time, resulting in a lower alveolar PCO 2 when CA was inhibited. The incomplete equilibration of CO 2 species in the pulmonary capillaries leads to a progressive increase in Pa CO 2 in the circulating blood and in blood sampled for analysis. Thus the Pa CO 2 determined in vitro reflects the complete equilibration among all forms of CO 2 in the blood and does not reflect the Pa CO 2 in vivo at the time of sampling.
A second concern is raised by our inability to state with certainty the location (i.e., extracellular and intracellular CA in both lung and muscle tissue) and/or isozyme(s) of CA that may have been inhibited by the dose and method of Acz administration used in the present study. However, the dose of Acz administered in Fig. 2 . Ensemble-averaged breath-by-breath response of ventilation and gas-exchange variables to step increase in work rate of moderate intensity (below ventilatory threshold) for a single subject in Acz (dashed line) and Con (solid line) sessions. Vertical dotted line indicates onset of exercise. V E, ventilation; V CO 2 , CO 2 output; PET O 2 , end-tidal PO 2 ; PET CO 2 , end-tidal PCO 2 ; V E/V O 2 , ventilatory equivalent for O 2 uptake V O 2 ; V E/V CO 2 , ventilatory equivalent for V CO 2 . Fig. 3 . Group mean (Ϯ SE) response of ventilation and gas exchange to step increase in work rate of moderateintensity (left) and heavy-intensity (right) exercise in Acz (s) and Con (r) sessions. Exercise was initiated at 6 min (vertical dotted line). For each subject, breath-by-breath data were averaged over 10-s periods corresponding to blood sampling and then averaged to provide mean group response. this study (10 mg/kg) is within the range (5-20 mg/kg) that has previously been shown to completely inhibit CA in most tissues (17) . We estimate that, for a 80-kg person (ϳ16 liters of extracellular fluid), the extracellular fluid Acz concentration would be ϳ225 µmol/l (or ϳ45 µmol/kg), which would result in a plasma Acz concentration severalfold higher than required to inhibit Ͼ99.95% of the total erythrocyte CA activity (38) . This dose of Acz is similar to that used in a study by Swenson and Maren (24) in which they reported that the erythrocyte isozymes CA I and CA II were ϳ93.3 and 99.3% inhibited, respectively. The time elapsed between Acz administration and the initiation of exercise was 30 min, a duration that may be sufficient for Acz to inhibit extracellular (i.e., CA IV associated with endothelial cells of both lung and muscle capillaries) but not the intracellular CA isozymes (9) .
V CO 2 during moderate-and heavy-intensity exercise. In agreement with previous studies (2, 24), steadystate V CO 2 was not affected by CA inhibition either at rest or at the end of moderate-or heavy-intensity exercise. Swenson and Maren (24) , using the same dose of Acz as used in the present study, showed that V CO 2 was not affected by CA inhibition during heavyintensity exercise because of compensatory mechanisms that maintained V CO 2 ; however, they did demonstrate that complete inhibition of CA would result in a lower V CO 2 during maximal exercise. Kowalchuk et al. (14) observed a reduction in peak V CO 2 (ϳ32%) during short-term maximal exercise after a protocol of Acz administration similar to that used in the present study. Whereas end-exercise V CO 2 during moderateand heavy-intensity exercise was similar in Con and Acz in the present study, the kinetics of V CO 2 were slowed at the onset of both moderate-and heavyintensity exercise in Acz, suggesting that, before achieving a steady-state, V CO 2 is depressed to a greater extent in the CA-inhibited condition. (Table 3 ) demonstrated a slowing of V CO 2 kinetics in Acz compared with Con. This slowing of V CO 2 kinetics during exercise ϾV ET in Acz may be expected as additional CO 2 is released from stores consequent to a potentiated compensatory hyperventilation in Acz (i.e., greater V E and V E/V CO 2 in Acz) that accompanies heavy-intensity exercise. The slowed V CO 2 kinetics and lower Amp 2 during the on-transition in Acz reinforces the observation that CO 2 elimination is impaired during the early transition to the higher work rate.
Ventilatory response during moderate-and heavyintensity exercise. Although V E was similar between conditions during loadless pedalling, V E/V CO 2 was higher during Acz compared with Con, suggesting that there was an additional stimulus to breathe. In addition, end-exercise V E was higher in the Acz studies during both moderate-and heavy-intensity exercise, consistent with previous studies (20, 22, 24) . Although it is generally held that CA inhibition stimulates V E by the metabolic acidosis that develops from the renal excretion of sodium bicarbonate (17) , it is possible that CO 2 retention in the tissues also stimulates V E (6). It is not possible from the results of the present study to discriminate between possible ventilatory stimuli or the sites of action. However, given that an accommodation of only 30 min followed the Acz administration, renal bicarbonate loss would not be significant, although sufficient time would be available for a tissue respiratory acidosis to develop.
In the present study, arterial [H ϩ ] measured at equilibrium was not different at rest between Con and Acz, but there was a small but significant acidosis in the Acz studies during loadless pedaling before the onset of exercise. Whereas a small but significant difference in arterial [H ϩ ] of ϳ2 nmol/l between Con and Acz was maintained throughout moderate-and heavy-intensity exercise, it is questionable whether it is of physiological significance. For example, in the present study, V E kinetics at the onset of moderateintensity exercise were slowed in Acz in contrast to the faster V E kinetics reported during an NH 4 Cl-induced metabolic acidosis (18) . The carotid bodies are considered the primary mediators of the compensatory hyperventilation associated with the metabolic acidosis accompanying heavy-intensity exercise (16, 19, 35, 37) and of the kinetics during the on-transient (phase 2) response to step increases in exercise intensity (16, 35) . Previous studies have shown that, under conditions of increased carotid body gain such as induced metabolic acidosis (18) or hypoxia (10, 11, 30) , V E kinetics are speeded. Conversely, reducing carotid body gain by induced metabolic alkalosis (18) , hyperoxia (10, 11, 30) , or carotid body resection (35) results in slowed V E kinetics. For exercise ϽV ET, phase 2 kinetics for V E and V CO 2 were isolated by applying the model to the response after phase 1 ( Table 2 ). The slowed V E during CA inhibition suggests that the carotid body gain was affected by Acz administration. Evidence from animal (12, 13, 26, 27) and human (23, 28) studies suggests that CA inhibition affects carotid body activity, but the response in humans during the non-steady-state exercise is presently not known. Although the slowing of V E kinetics during the moderate-intensity exercise after CA inhibition is consistent with altered carotid body activity, this effect cannot be discriminated from the possible effects of the slowed V CO 2 response that also occurred with CA inhibition (discussed in Interaction between V CO 2 
and V E kinetics during moderate-intensity exercise).
A surprising finding in the present study was the speeding of V E kinetics during exercise ϾV ET after the administration of Acz compared with Con. The mechanism responsible for the faster V E kinetics is unclear and is particularly difficult to reconcile given the slowing of V E kinetics during exercise ϽV ET. However, the heavy-intensity exercise bouts were performed ϳ60 min after the infusion of Acz (i.e., after 2 bouts of ϽV ET exercise), which may have potentiated the response of the central chemoreceptors. This hypothesis is speculative, but the issue does warrant further investigation, because Rausch et al. (19) suggested previously that a central chemosensory mechanism was responsible for a Interaction between V CO 2 and V E kinetics during moderate-intensity exercise. During the on-transition to moderate-intensity exercise, both V CO 2 and V E kinetics were slowed during Acz compared with during Con. Despite the inability to clearly define a control mechanism, considerable evidence has been reported to suggest that V E kinetics are mediated by the flow of CO 2 to the lungs (5, 31, 33, 34, 36) . By using controlled volitional hyperventilation to lower body CO 2 stores before the onset of exercise, Ward et al. (31) demonstrated a slowing of V CO 2 kinetics and a consequent slowing of V E kinetics. In the present study, CA inhibition resulted in a higher V E/V CO 2 and lower PET CO 2 at rest. Thus, similar to the previous study (31) , lowering of the body CO 2 stores before exercise may in part explain the slower V CO 2 kinetics and, subsequently, the slower V E kinetics found in this study. Although this possibility cannot be discounted, this effect would not be expected to contribute significantly to the slowing of either V CO 2 or V E because PET CO 2 was only ϳ3 Torr lower during Acz than Con. This may be compared with the marked decrease in PET CO 2 of 10-15 Torr after hyperventilation in the study of Ward et al. (31) . As already discussed, the slower V CO 2 kinetics during moderate-intensity exercise appear to be associated with a direct effect of CA inhibition on tissue CO 2 retention, CO 2 transport, and/or CO 2 reaction kinetics (at either the muscle or lung) and not by a substantial unloading of CO 2 stores by an Acz-induced hyperventilation.
Summary. The acute inhibition of CA with Acz was associated with a slowing of V CO 2 kinetics during whole body, constant-load exercise performed below and above the V ET. This slowing of V CO 2 kinetics may be a consequence of greater tissue CO 2 retention and/or slowed equilibration of CO 2 in the blood and across the pulmonary capillaries after CA inhibition. The mechanism for the slowed elimination of CO 2 during the on-transient to exercise is yet unknown. During exercise ϽV ET, V E kinetics were slowed in the Acz studies, adding further support to the close coupling observed between V E and V CO 2 . However, the possibility that an attenuation of carotid body activity contributed to the slowing of V E kinetics, independent of CO 2 , warrants further investigation. That speeding of V E kinetics during exercise ϾV ET may reflect an increase in central chemoresponsiveness associated with tissue CO 2 retention also warrants investigation.
